首页> 外文期刊>Journal of Cardiovascular Development and Disease >Genetic Regulation of Sinoatrial Node Development and Pacemaker Program in the Venous Pole
【24h】

Genetic Regulation of Sinoatrial Node Development and Pacemaker Program in the Venous Pole

机译:静脉极中窦房结的发育和起搏器程序的遗传调控。

获取原文
           

摘要

The definitive sinoatrial node (SAN), the primary pacemaker of the mammalian heart, develops from part of pro-pacemaking embryonic venous pole that expresses both Hcn4 and the transcriptional factor Shox2. It is noted that ectopic pacemaking activities originated from the myocardial sleeves of the pulmonary vein and systemic venous return, both derived from the Shox2+ pro-pacemaking cells in the venous pole, cause atrial fibrillation. However, the developmental link between the pacemaker properties in the embryonic venous pole cells and the SAN remains largely uncharacterized. Furthermore, the genetic program for the development of heterogeneous populations of the SAN is also under-appreciated. Here, we review the literature for a better understanding of the heterogeneous development of the SAN in relation to that of the sinus venosus myocardium and pulmonary vein myocardium. We also attempt to revisit genetic models pertinent to the development of pacemaker activities in the perspective of a Shox2-Nkx2-5 epistatic antagonism. Finally, we describe recent efforts in deciphering the regulatory networks for pacemaker development by genome-wide approaches.
机译:最终的窦房结(SAN),是哺乳动物心脏的主要起搏器,由表达Hcn4和转录因子Shox2的促心脏起搏的胚胎静脉极发育而成。值得注意的是,异位起搏活动起源于肺静脉的心肌套和全身静脉回流,这两者均源自静脉极中的Shox2 + 前起搏细胞,引起房颤。但是,胚胎静脉极细胞中起搏器特性与SAN之间的发展联系仍未明确。此外,用于开发SAN异类种群的遗传程序也未得到足够的重视。在这里,我们回顾文献以更好地理解SAN相对于静脉窦心肌和肺静脉心肌的异质发展。我们还试图从Shox2-Nkx2-5上位性拮抗作用的角度重新审视与起搏器活动发展有关的遗传模型。最后,我们描述了最近在通过全基因组方法破译起搏器开发的监管网络方面所做的努力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号